Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 1999-08-04 (26 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ROUBAIX (59100), Nord
PHARMACIE DE LA POTENNERIE : revenue, balance sheet and financial ratios
PHARMACIE DE LA POTENNERIE is a French company
founded 26 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ROUBAIX (59100),
this company of category PME
shows in 2024 a revenue of 1.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA POTENNERIE (SIREN 423864610)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
1 669 595 €
N/C
N/C
1 785 809 €
1 674 552 €
1 687 504 €
1 665 706 €
1 662 901 €
1 741 191 €
Net income
110 872 €
103 975 €
131 000 €
235 665 €
183 540 €
157 704 €
171 216 €
169 257 €
169 886 €
168 980 €
EBITDA
N/C
136 744 €
N/C
N/C
245 956 €
209 115 €
226 300 €
225 222 €
240 507 €
245 957 €
Net margin
N/C
6.2%
N/C
N/C
10.3%
9.4%
10.1%
10.2%
10.2%
9.7%
Revenue and income statement
In 2025, PHARMACIE DE LA POTENNERIE generates positive net income of 111 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 169 k€ -> 111 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
110 872 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 84%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
84.354%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
40.975%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA POTENNERIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
144.338
137.726
124.615
116.91
109.231
122.068
91.603
86.143
87.289
84.354
Financial autonomy
33.346
35.064
36.569
38.338
39.009
36.684
43.348
44.093
41.856
40.975
Repayment capacity
3.232
3.135
3.171
2.889
3.015
3.315
None
None
4.161
None
Cash flow / Revenue
9.956%
10.313%
9.811%
9.978%
9.162%
9.97%
None%
None%
6.277%
None%
Sector positioning
Debt ratio
84.352025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average+6 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE LA POTENNERIE (84.35) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
40.98%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average-10 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE LA POTENNERIE (41.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
4.16 years2024
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Average
In 2024, the repayment capacity of PHARMACIE DE LA POTENNERIE (4.16) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 34.06. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
34.065
Liquidity indicators evolution PHARMACIE DE LA POTENNERIE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
60.74
57.04
61.713
59.339
54.426
118.467
127.322
93.452
63.412
34.065
Interest coverage
0.492
0.0
0.0
0.0
0.339
1.394
None
None
2.136
None
Sector positioning
Liquidity ratio
34.062025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch-10 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE LA POTENNERIE (34.06) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
2.14x2024
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Average
In 2024, the interest coverage of PHARMACIE DE LA POTENNERIE (2.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA POTENNERIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
27 128 €
64 138 €
62 264 €
57 206 €
48 830 €
13 572 €
0 €
0 €
35 245 €
0 €
Inventory turnover (days)
13
14
16
15
18
14
0
0
17
0
Customer payment term (days)
4
4
5
5
1
2
0
0
0
0
Supplier payment term (days)
40
37
39
34
37
36
0
0
46
0
Positioning of PHARMACIE DE LA POTENNERIE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE LA POTENNERIE is estimated at
1 761 214 €
(range 1 195 168€ - 2 763 588€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1195k€1761k€2763k€
1 761 214 €Range: 1 195 168€ - 2 763 588€
NAF 5 année 2025
Valuation method used
Net Income Multiple
110 872 €
×
15.9x
=1 761 215 €
Range: 1 195 169€ - 2 763 589€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA POTENNERIE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA POTENNERIE
What is the revenue of PHARMACIE DE LA POTENNERIE ?
The revenue of PHARMACIE DE LA POTENNERIE in 2024 is 1.7 M€.
Is PHARMACIE DE LA POTENNERIE profitable?
Yes, PHARMACIE DE LA POTENNERIE generated a net profit of 111 k€ in 2025.
Where is the headquarters of PHARMACIE DE LA POTENNERIE ?
The headquarters of PHARMACIE DE LA POTENNERIE is located in ROUBAIX (59100), in the department Nord.
Where to find the tax return of PHARMACIE DE LA POTENNERIE ?
The tax return of PHARMACIE DE LA POTENNERIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA POTENNERIE operate?
PHARMACIE DE LA POTENNERIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart